PrEP Biopharm Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $32.4M
Latest Deal Amount
  • Investors
  • 2

PrEP Biopharm General Information

Description

Operator of a biopharmaceutical company intended to develop a new approach to leverage the innate immune system to address unmet medical needs. The company's product is a nasally administered, broad-spectrum agent that leverages the innate immune system to prevent upper respiratory tract viral infections, enabling doctors to easily help high-risk patients who currently suffer substantial morbidity and mortality from respiratory viral infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Queen Mary Bioenterprises Innovation Centre
  • 42 New road
  • London E1 2AX
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PrEP Biopharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 16-Nov-2015 $32.4M 000.00 Completed Startup
To view PrEP Biopharm’s complete valuation and funding history, request access »

PrEP Biopharm Executive Team (4)

Name Title Board Seat Contact Info
Ryan Muldoon Co-Founder, Chief Executive Officer & Board Member
Bruce Malcolm Ph.D Co-Founder & Chief Scientific Officer
Timothy Jenkins Ph.D Vice President of Clinical Development
Ron Turner MD Chief Medical Officer
To view PrEP Biopharm’s complete executive team members history, request access »

PrEP Biopharm Board Members (7)

Name Representing Role Since
Cathal Friel Self Board Member 000 0000
Clive Page Ph.D PrEP Biopharm Board Member 000 0000
James Cornelius PrEP Biopharm Board Member 000 0000
Kym Lynn Denny hVIVO Board Member 000 0000
Ryan Muldoon PrEP Biopharm Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

PrEP Biopharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrEP Biopharm Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
hVIVO Corporation Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
To view PrEP Biopharm’s complete investors history, request access »